These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension]. Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092 [No Abstract] [Full Text] [Related]
3. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects]. Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770 [No Abstract] [Full Text] [Related]
4. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris]. Cherchi A; Fonzo R; Lai C; Mercuro G Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022 [No Abstract] [Full Text] [Related]
5. [Acute hemodynamic effect of labetalol in severe hypertension]. Omvik P; Lund-Johansen P Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057 [No Abstract] [Full Text] [Related]
6. [Effect of labetalol and chlorthalidone on exercise tolerance in hypertensive subjects]. Raffo M; Cherchi A; Sau F; Pirisi R; Seguro C; Pisano MR Boll Soc Ital Cardiol; 1979; 24(6):657-66. PubMed ID: 551798 [No Abstract] [Full Text] [Related]
7. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol. Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function]. Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536 [No Abstract] [Full Text] [Related]
9. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat]. Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576 [No Abstract] [Full Text] [Related]
10. [Ergometric control in hypertension treatment with labetalol]. Prohaska H; Honetz N Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661 [No Abstract] [Full Text] [Related]
11. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin. Buch J; Rasmussen S Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128 [TBL] [Abstract][Full Text] [Related]
12. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study]. Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696 [TBL] [Abstract][Full Text] [Related]
13. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)]. Lüben V; Rieder W; Zierski J; Hempelmann G Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326 [TBL] [Abstract][Full Text] [Related]
14. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension]. Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989 [No Abstract] [Full Text] [Related]
15. Proceedings of the Second Symposium on Labetalol, London, March 1979. Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-244S. PubMed ID: 526409 [No Abstract] [Full Text] [Related]
16. [Treatment of hypertension by labetalol (author's transl)]. Sternon J; Melot C; Contu E Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430 [No Abstract] [Full Text] [Related]
17. A five-year study of labetalol in hypertension. Kane J; Gregg I; Stephens MD Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466 [No Abstract] [Full Text] [Related]
18. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans. Vas A; Gachályi B; Káldor A Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757 [No Abstract] [Full Text] [Related]